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Summary
Anaerobic bacteria dominate the human normal
microbiota, but strikingly little is known about these
commensals. Finegoldia magna is a Gram-positive
anaerobe found in the skin and at other non-sterile
body surfaces, but it is also an opportunistic
pathogen. This study describes a novel protein
designated FAF (F. magna adhesion factor) and
expressed by more than 90% of F. magna isolates.
The protein is present in substantial quantities at
the F. magna surface but is also released from the
surface. FAF forms large protein aggregates in solu-
tion and surface-associated FAF causes bacterial
clumping. In skin F. magna bacteria were localized to
the epidermis, where they adhere to basement
membranes. FAF was found to mediate this adhesion
via interactions with BM-40, a basement membrane
protein. The biological signiﬁcance of FAF is further
underlined by the observation that it blocks the activ-
ity of LL-37, a major human antibacterial peptide.
Altogether, the data demonstrate that FAF plays an
important role in colonization and survival of
F. magna in the human host.
Introduction
In the normal human microbiota that colonizes the skin
and mucous membranes anaerobic bacterial species
dominate, especially in the gastrointestinal tract where
more than 90% of the bacterial population consist of obli-
gate anaerobes (Tlaskalová-Hogenová et al., 2004). The
abundance and signiﬁcance of anaerobic bacteria, in the
normal microbiota and in clinical infections, are probably
highly underestimated because of problems obtaining
good quality anaerobic specimens, and experimental dif-
ﬁculties connected with the growing and handling of these
bacteria. The Gram-positive coccus Finegoldia magna
(formerly Peptostreptococcus magnus) is one of the most
ubiquitous anaerobic species in the skin (Higaki and
Morohashi, 2003), but it also inhabits the oral cavity and
the gastrointestinal and urogenital tracts (Murdoch, 1998).
Apart from being a commensal F. magna is also an oppor-
tunistic pathogen, and among the anaerobic bacteria of
the normal microbiota, F. magna is the species most fre-
quently isolated in pure culture from patients with clinical
infections. Typical infections connected with F. magna
are soft tissue abscesses, bone/joint infections, wound
infections and vaginosis (Murdoch, 1998; Stephens et al.,
2003). Rare cases of prosthetic valve endocarditis caused
by F. magna have also been reported (van der Vorm et al.,
2000; Bassetti et al., 2003).
Possible F. magna pathogenicity factors have been
identiﬁed, including capsule formation (Brook, 1986) and
production of various enzymes, such as collagenase and
gelatinase (Krepel et al., 1992). Most strains express a
subtilisin-like enzyme, SufA, showing proteolytic activity
against antimicrobial molecules like LL-37 and MIG/
CXCL9 (Karlsson et al., 2007). Approximately 10% of
F. magna isolates express a surface protein, protein L,
with affinity for immunoglobulin light chains (Björck, 1988),
whereas the majority of F. magna isolates from patients
with bacterial vaginosis expresses protein L (Kastern
et al., 1990). A role for protein L in F. magna pathogenicity
is also indicated by the ﬁnding that when expressed at
the surface of Streptococcus gordonii bacteria, protein L
enhances their ability to colonize the vaginal mucosa of
mice (Ricci et al., 2001). Another surface protein of
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and Björck, 1994) is commonly expressed by isolates
from localized suppurative infections, such as deep
wound infections (de Château et al., 1996), suggesting
that PAB could also contribute to the pathogenicity of
F. magna.
Very limited information is available concerning the
molecular mechanisms that promote the colonization and
survival of anaerobic commensals in the skin and at other
non-sterile sites. In the present work we describe the
properties of a novel protein of F. magna, with an impact
on some basic prerequisites for the relationship between
this commensal and its human host.
Results
Surface protein of F. magna induces
bacterial aggregation
When grown in liquid medium most clinical isolates of
F. magna form visible aggregates. The starting point for
the present work was the question how this property inﬂu-
ences the biology of F. magna and how to explain the
molecular basis for the aggregation. In contrast to a non-
aggregating isolate (strain 505), bacteria of the ALB8
strain rapidly form large aggregates in the test tube
(Fig. 1A). Analysis of the bacterial cultures by electron
microscopy conﬁrmed this observation (Fig. 1B, left
panel) and revealed hair-like surface projections on ALB8
bacteria, mediating interactions between neighbouring
bacterial cells. Such projections were not present at the
surface of 505 bacteria (Fig. 1B, right panel). Following
treatment of ALB8 with proteases or cyanogen bromide
(CNBr) that removed the surface projections (Fig. 2B), the
bacteria no longer formed aggregates suggesting that
surface proteins play a role in bacterial clumping. CNBr
cleavage released two quantitatively dominating protein
fragments of apparently 50 and 53 kDa respectively, as
determined by SDS-PAGE analysis (Fig. 2A, STAIN,
lane 1). These were subjected to N-terminal amino acid
sequencing analysis, and identical sequences were
obtained from both bands (AEKAPKITENLSEEQAA),
suggesting that they represent fragments of the same
protein. When the database was searched, no sequences
related to the obtained peptide sequence were found.
Subsequent work described below showed that this
novel protein promotes the adhesion and colonization of
F. magna. It was therefore designated protein FAF
(F. magna adhesion factor).
Protein FAF is a self-associating protein
For cloning of the gene encoding protein FAF, a primer
was constructed based on the N-terminal sequence
Fig. 1. Analysis of F. magna aggregation.
A. F. magna strains ALB8 () and 505 ()
were grown under strict anaerobic conditions
at 37°C for 3 days in TH broth supplemented
with 0.5% Tween-80. Bacteria were
resuspended and left to settle at 4°C. The
optical density (620 nm) in the upper half of
the test tubes was measured at various time
points.
B. Left panel: scanning electron micrographs
showing ALB8 and 505 bacteria from 3 days
cultures in TH broth. The bar represents
10 mm. Right panel: Transmission electron
micrographs of the same cultures. The bar
represents 0.5 mm.
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cell wall-spanning LPXTG motif, a sequence known to
be conserved among Gram-positive surface proteins
(Schneewind et al., 1993), a PCR product of 1.7 kb was
generated with chromosomal DNA of F. magna strain
ALB8 as the template. The PCR product was puriﬁed,
cloned and sequenced (see Experimental procedures).
Analysis of the protein sequence deduced from the nucle-
otide sequence (GenBank accession number AY192570)
shows a pre-protein of 616 amino acids with a predicted
signal sequence of 27 amino acid residues (see sche-
matic representation Fig. 2C). The mature protein of 589
amino acids has a molecular mass of 64.7 kDa. InterPro
domain searches (Quevillon et al., 2005) revealed that
FAF in its C-terminal part has a cell wall-spanning region,
a membrane anchor and an intracellular charged tail
typical of surface proteins of Gram-positive bacteria. The
sequence contains no internal repeats but has high
alanine content, especially in the N-terminal half. The
C-terminal region also contains a Cna protein B-type
domain, found in Staphylococcus aureus collagen-binding
protein (Deivanayagam et al., 2000).
If protein FAF is responsible for the aggregation ofALB8
bacteria, FAF should be able to self-associate. To address
this question the protein was expressed in Escherichia
coli in fusion with glutathione S-transferase (GST). The
GST-tag was removed, and recombinant FAF was used in
various binding studies. The size of the 50 kDa fragment
generated by CNBr cleavage of ALB8 bacteria (Fig. 2A,
lane 1) corresponds well to the methionine residue at
position 461 in the sequence of protein FAF (Fig. 2C). In
contrast, the 53 kDa band most likely represents a frag-
ment that is spontaneously shedded from the bacterial
surface as substantial amounts of such a FAF fragment
are found in ALB8 growth medium (Fig. 2A, lane 2).
Radiolabelled protein FAF interacts with both the 50 and
the 53 kDa fragments, as well as with the full-length
recombinant molecule (Fig. 2A, BLOT). In contrast, the
albumin-binding protein PAB, which is also expressed at
the surface of ALB8 bacteria (de Château and Björck,
1994), did not bind the radiolabelled probe (Fig. 2A,
lane 4).
To map the self-associating region of FAF, fragments
of the protein were constructed and recombinantly
expressed in fusion with GST (Fig. 2C). The various FAF
fragments and protein PAB were applied onto a polyvi-
nylidene diﬂuoride (PVDF) membrane and probed with
125I-FAF. Fragment III, covering the C-terminal part and
Fig. 2. Protein FAF self-associates.
A. Solubilized surface proteins from F. magna ALB8 bacteria were
separated by SDS-PAGE. Two identical gels (10%) were run
simultaneously; one was stained with Coomassie blue (STAIN), and
one was blotted onto a PVDF membrane and probed with
125I-labelled recombinant FAF (BLOT). Lane 1: proteins released
with CNBr; lane 2: proteins shedded from the surface of ALB8
bacteria and puriﬁed as described (see Experimental procedures);
lane 3: recombinant FAF; lane 4: recombinant protein PAB. Bands
indicated in the ﬁgure with a star were excised and subjected to
N-terminal amino acid sequencing.
B. Electron micrographs after negative staining of untreated and
CNBr-treated ALB8 bacteria. The bar represents 100 nm.
C. Schematic representation of FAF. The signal sequence (Ss), the
alanine rich region (A), the methionine residue (Met), the wall
spanning (W) and the membrane spanning (M) regions are
indicated. The fragment obtained by CNBr treatment and the
recombinantly expressed fragments of FAF are shown below.
Numbers refer to amino acid residue positions.
D. Different amounts of FAF, fragments of FAF, protein PAB and
GST were applied onto a PVDF membrane. The membrane was
incubated with
125I-labelled FAF, and binding was detected using
the Fuji Imaging System.
E. The binding of
125I-labelled FAF to ALB8 bacteria at a
concentration of 2 ¥ 10
9 cfu ml
-1 was inhibited with various amounts
of unlabelled intact FAF (), fragment I (), fragment II ()o r
fragment III () of FAF (see 2C) or protein PAB ( ).
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binding occurred to the N-terminal fragments I and II
(Fig. 2D). Protein PAB and the GST-tag alone did not bind
125I-FAF. In competitive binding experiments the full-length
molecule and fragment III efficiently blocked the binding of
125I-labelled FAF to ALB8 bacteria. A partial inhibition was
seen with the N-terminal fragment I (Fig. 2E). Despite a
weak binding to FAF in slot blot, fragment II did not inhibit
the binding of radiolabelled FAF to ALB8 (Fig. 2E). This
discrepancy probably reﬂects that different affinities are
required for a positive result and/or that the binding
epitopes are differently exposed in the two experimental
systems. Again protein PAB had no affinity for FAF. Taken
together the results demonstrate that FAF, through self-
association, contributes to the bacterial aggregation. Most
likely, these interactions mainly occur in the C-terminal
half of the molecule. Finally, antibodies raised against
recombinant FAF further enhanced ALB8 sedimentation
(data not shown), which underlines the importance of FAF
in mediating bacterial aggregation.
Secondary structure analysis of protein FAF
Circular dichroism (CD) spectroscopy was used to
analyse the secondary structure of FAF. Far UV spectra
recorded at 20°C revealed that the structure of the mol-
ecule is predominantly a-helical, as indicated by the
maximum below 200 nm and the double minima at 208
and 222 nm (Fig. 3A). Predictive secondary structure
analysis according to the algorithm of Chou-Fasman and
Robson-Garnier showed that most of FAF exhibits a
strong a-helical potential.Analysis with the coiled-coil pre-
diction algorithm of Lupas et al. in Macstripe (Lupas et al.,
1991) yielded high coiled-coil forming probabilities in the
major extracellular part (amino acids 28–417) of the
molecule. The probability curve depicted in Fig. 3B indi-
cates that some short regions in the N-terminal part, the
C-terminal part of the A domain and the cell wall- and
transmembrane-spanning regions of FAF do not adopt a
coiled-coil structure. The secondary structure of the
protein is similar to the a-helical coiled-coil structure of
Streptococcus pyogenes M proteins (Phillips et al., 1981;
Fischetti, 1989; Nilson et al., 1995). Protein FAF sponta-
Fig. 3. Secondary structure of protein FAF.
A. Recombinant intact FAF at a concentration of 0.2 mg ml
-1 was
analysed by CD spectroscopy. The far UV spectral region at 20°C
is shown.
B. Coiled-coil prediction of FAF according to (Lupas et al., 1991)
using the Macstripe program showing the probability on the y-axis
and amino acid residue numbers on the x-axis.
C. Electron micrographs after negative staining of FAF shedded
from ALB8 bacteria (ALB8 extract) or recombinant FAF (rFAF). The
bar represents 100 nm (left panel). Right panel: selected particles
shown at higher magniﬁcation (bar = 50 nm).
698 I-M. Frick etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 70, 695–708neously released from ALB8 bacteria and the recombi-
nantly expressed FAF were further analysed by electron
microscopy after negative staining. The rod-like structure
of the molecule ﬁts well with a coiled-coil a-helical struc-
ture, and no difference could be observed between the
two preparations (Fig. 3C).
Distribution of the faf gene in F. magna strains
To investigate the expression of protein FAF in isolates of
F. magna, 30 strains, including ALB8, were tested for
binding of radiolabelled FAF. Among these, two were
normal skin isolates and the others were from different
clinical infections: urethritis, infected skin wounds,
abscesses and vaginosis (see Experimental procedures).
Binding varied between 9% and 28% of added radioac-
tivity as compared with a background binding of 7% to 505
bacteria that lacks protein FAF. Surprisingly, PCR analy-
ses of these isolates using oligonucleotides correspond-
ing to the 5′- and the 3′-ends of the faf gene (faf1 and faf2)
only generated the expected fragment of 1700 bp in a few
strains (13.8%). However, when primers corresponding
to other regions of the gene were used, 28 of the 30
strains were found to carry the gene (see Experimental
procedures). The results indicate a sequence variation of
FAF, mainly in the N-terminal part.
Five of the strains containing the faf gene (L3410, 1462,
2133, ELTI and 1766) were subjected to CNBr cleavage
followed by SDS-PAGE analysis of released material.
Similar fragments as those obtained for ALB8 were
obtained from all strains (Fig. 4, STAIN). In Western blot
the quantitatively dominating fragments of 50 and 53 kDa,
released from all tested strains, reacted with antibodies
raised against FAF from ALB8 bacteria, suggesting that
homologous epitopes are present in these protein frag-
ments (Fig. 4, BLOT). Radiolabelled FAF also bound to
the fragments, supporting the presence of FAF homo-
logues (data not shown). The dominating 50 kDa bands
from strains 2133 and 1766 were subjected to N-terminal
amino acid sequencing and the obtained sequences
(2133: EKNSKENSYTEE; 1766: DYNKAEESYTYL) dif-
fered to that of ALB8. The faf genes of the F. magna
strains L3410, 1462, 2133, ELTI and 1766 were
sequenced, and the derived amino acid sequences were
compared with that of FAF from strain ALB8 (Fig. S1).
Strain L3410 expresses a protein almost identical to FAF
of ALB8 (99% similarity), and the other strains express
FAF homologues showing an overall sequence similarity
of around 50% to ALB8 FAF (Fig. S1). There is a higher
variability in the N-terminal regions, while the C-terminal
halves are more conserved. Interestingly, FAF from
strains 2133 and 1462 are identical, and strain ELTI
has a FAF homologue closely related to these (94.1%
similarity). Furthermore, in the complete genome
sequence of F. magna ATCC 29328 strain recently
reported (Goto et al., 2008), there is a FAF homologue
displaying an overall sequence similarity of 75% to ALB8
FAF with a higher similarity in their C-terminal parts (89%)
as compared with the N-terminal regions (60%) (Fig. S1).
The data demonstrate that protein FAF variants are
present at the surface of most F. magna strains.
FAF interacts with the basement membrane
protein BM-40
Because FAF is a surface protein, we speculated that it
might function as an adhesin, mediating bacterial interac-
tions with skin tissue. Thus, bacterial cultures ofALB8 and
505 were incubated with human skin biopsies. Following
a washing step the biopsies were incubated for 48 h at
37°C under strict anaerobic conditions allowing bacterial
growth. Scanning electron microscopy (SEM) demon-
strated that ALB8 bacteria adhere to the basement mem-
brane between epidermis and dermis (Fig. 5A), whereas
505 bacteria did not adhere to the tissue (Fig. 5B).
Basement membranes are mainly formed by indepen-
dent networks of collagen IV and laminin, linked by other
molecules, such as nidogen and BM-40 (for a review see
Timpl, 1996). To analyse a possible interaction between
FAF and various protein components of basement mem-
Fig. 4. Analysis of FAF in seven F. magna
strains. Proteins released by CNBr from the
isolates were separated by SDS-PAGE. Two
identical gels (10%) were run simultaneously;
one was stained with Coomassie blue
(STAIN), and one was blotted onto a PVDF
membrane and probed with antibodies against
FAF. Lane 1: strain 505; lane 2: strain ALB8;
lane 3: strain L3410; lane 4: strain 1462; lane
5: strain 2133; lane 6: strain 1766; lane 7:
strain ELTI. Bands indicated in the ﬁgure with
a star were excised and subjected to
N-terminal amino acid sequencing.
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nine proteins (see Experimental procedures) were immo-
bilized, and FAF was applied and left to interact to the
level of saturation. Of the tested proteins, only BM-40
showed affinity for protein FAF (Fig. 6A). Association and
dissociation constants for the interaction were calculated
[7.5 ¥ 108 (1/M) and 1.3 ¥ 10-9 (M) respectively] and dem-
onstrated a high affinity for BM-40. Protein PAB had no
affinity for any of the proteins. Using the various FAF
fragments in a slot binding assay with radiolabelled
BM-40 as the probe, the binding site for BM-40 on protein
FAF was localized to the C-terminal part of the molecule
(Fig. 6B). Again, there was no interaction between protein
PAB and BM-40. Moreover, the material solubilized with
CNBr from the FAF-expressing strains (see Fig. 4) bound
radiolabelled BM-40 in slot blot experiments (data not
shown). Next, FAF–BM-40 complexes formed in solution
were analysed by electron microscopy following negative
staining. The results conﬁrm that the C-terminal part of
FAF is the major binding region for BM-40 (Fig. 6C). Most
likely, this binding does not compete with FAF self-
association. Thus, when radiolabelled BM-40 together
with a 1000-fold molar excess amount of unlabelled FAF
was incubated with FAF immobilized on a PVDF mem-
Fig. 5. F. magna bacteria adhere to basement membranes.
Human skin biopsies were incubated with ALB8 or 505 bacteria for
1 h at room temperature. Non-adherent bacteria were removed by
washing in PBS, and the biopsies were incubated anaerobically at
37°C for 48 h, washed with PBST, ﬁxed and prepared for SEM. A.
ALB8 bacteria; B. 505 bacteria. The arrows point at ALB8 colonies
and the arrowheads point at the basement membrane covering the
junction between epidermis and dermis. The bar represents 10 mm.
Fig. 6. FAF interacts with BM-40.
A. Surface plasmon resonance spectroscopy showing the affinity
between the basement membrane component BM-40 and FAF.
BM-40 was immobilized onto a CM5 sensorchip, and protein FAF
was injected at concentrations from 31 to 250 nM at a ﬂow rate of
50 ml min
-1.
B. Intact FAF, fragments of FAF (see Fig. 2C), protein PAB and
GST were applied onto PVDF membranes. Membranes were
probed with
125I-labelled BM-40, and binding was detected using
the Fuji Imaging System.
C. Electron micrographs after negative staining of FAF in complex
with BM-40. The globular N-terminal GST-tag of recombinant FAF
is indicated by arrows. BM-40 binds to the C-terminal part of FAF
(arrowheads). At the concentrations used (10 nM) no FAF dimer
formation was observed. The bar represents 25 nm.
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shown).
FAF-expressing F. magna colocalizes with BM-40 in
human skin
To investigate whether FAF mediates adhesion of
F. magna to skin tissue via the interaction with BM-40,
colocalization studies were performed. Human skin biop-
sies were incubated with ALB8 bacteria for 1 h, and fol-
lowing extensive washing bacteria were allowed to
multiply anaerobically for 48 h. The biopsies were then
incubated with antibodies against FAF and BM-40
labelled with colloidal gold, 10 and 5 nm respectively.
Analysis by electron microscopy shows bacterial cells in
the epidermal compartment close to the basement mem-
brane (Fig. 7A). Immuno-staining identiﬁes FAF on the
bacterial surface, and BM-40 present in the basement
membrane colocalizes with protein FAF (Fig. 7B).
Next, we investigated if endogenous F. magna could be
identiﬁed in human skin. SEM of skin biopsies identiﬁed
colonies of cocci at the epidermal/dermal junction (Fig. 7C
and D). Following immuno-labelling with gold-labelled
antibodies against FAF, thin sections of skin biopsies were
analysed by electron microscopy. The detection of
immuno-labelled bacteria in skin biopsies demonstrates
the presence of FAF in vivo (Fig. 7E and F), and in
summary the results demonstrate that F. magna colonizes
human skin through the interaction between FAF and
BM-40.
The antibacterial activity of LL-37 is blocked with
protein FAF
To successfully colonize its host bacteria needs to over-
come innate defence mechanisms, such as antibacterial
peptides. Cathelicidins and defensins are two major fami-
lies of antibacterial peptides having broad bactericidal
activity against Gram-positive and Gram-negative bacte-
ria (for references, see Bevins, 2003; Boman, 2003).
When LL-37 (a cathelicidin) and a-defensin were applied
to a PVDF membrane, radiolabelled FAF was found to
bind LL-37 but not a-defensin (Fig. 8A). Using the various
FAF fragments as probes, it was demonstrated that
regions in both the N- and C-terminal regions are required
for full binding of LL-37 (not shown).
The bactericidal effect of LL-37 was tested against
F. magna strains ALB8 and 505. Signiﬁcantly higher con-
Fig. 7. FAF-expressing F. magna bacteria
are found at the basement membrane in
human epidermis and colocalize with BM-40.
Human skin biopsies were anaerobically
incubated with F. magna ALB8 bacteria for
48 h at 37°C and prepared for ultrathin
sectioning/transmission electron microscopy.
A. An overview showing the epidermis, the
basement membrane at the epidermal/dermal
junction (B) and dermis. Arrows point at ALB8
bacteria. The bar represents 1 mm.
B. The square in A indicates the selected area
shown at higher magniﬁcation here.
FAF-expressing ALB8 bacteria colocalize with
BM-40 at the basement membrane (B).
Arrows point at anti-FAF antibodies (10 nm
gold) and arrowheads point at anti-BM-40
antibodies (5 nm gold). The bar represents
100 nm.
C. Scanning electron micrograph of a thin
section of a skin biopsy from a healthy donor.
Colonies of cocci (arrows) are found at
the basement membrane (B) at the
epidermal/dermal junction.
D. Interpretation of C in pseudocolours.
The scale bar represents 10 mm.
E. Ultrathin sectioning and transmission
electron microscopy of a skin biopsy from a
healthy donor after immuno-labelling of
protein FAF. Bacteria labelled with colloidal
gold are seen at the basement membrane
(B). The bar represents 100 nm.
F. A selected area indicated by the square in
E at higher resolution is shown. Fibrillar
protrusions labelled with colloidal gold
(arrows) extend from the bacterial surface and
interact with the basement membrane (B).
The bar represents 50 nm.
Colonization and survival of Finegoldia magna 701
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 70, 695–708centrations of LL-37 were required to kill the FAF-
expressing strain ALB8 as compared with the non-
expressing 505 strain (Fig. 8B). As protein FAF is also
shedded from the bacterial surface (see Fig. 2A, lane 2),
we hypothesized that soluble FAF could block the activity
of LL-37. In these experiments we used 505 bacteria. The
inhibitory effect of recombinantly expressed protein FAF
was tested at a bactericidal concentration (2.2 mM) of
LL-37, and as shown in Fig. 8B, FAF dose-dependently
blocked the killing by LL-37. The ALB8 and 505 strains
were also incubated with gold-labelled LL-37 (5 nm gold)
and anti-FAF antibodies (20 nm gold), and following
negative staining bacteria were analysed by electron
microscopy. The anti-FAF antibodies bound to the hair-
like projections protruding from the surface of ALB8 bac-
teria, and LL-37 bound to these projections (Fig. 8C).
ALB8 bacteria appeared intact, whereas ejected cytoplas-
mic material was observed in 505 bacteria indicating a
disintegrated cell membrane. LL-37 was also found at the
bacterial cell membrane of these bacteria and within
Fig. 8. Protein FAF interferes with the
antibacterial activity of LL-37.
A. Various amounts of the antibacterial
peptides LL-37 and a-defensin and BSA
were applied to a PVDF membrane. The
membrane was incubated with
125I-labelled
FAF, and binding was detected using the Fuji
Imaging System.
B. Left panel: F. magna strains ALB8 and 505
(2 ¥ 10
6 cfu ml
-1) were incubated with the
antibacterial peptide LL-37 at various
concentrations for 1 h at 37°C, and the cfu
were determined. The bars represent the
mean  standard error of the mean of at least
three experiments. Right panel: The
bactericidal activity of LL-37 at 2.2 mM against
505 bacteria was inhibited with recombinant
FAF. Experiments were repeated at least
three times and a representative experiment
is shown.
C. ALB8 and 505 bacteria were grown under
strict anaerobic conditions at 37°C for 3 days
in TH broth supplemented with 0.5%
Tween-80. Bacteria were washed and
incubated with LL-37 and anti-FAF antibodies
labelled with colloidal gold for 30 min at room
temperature (LL-37, 5 nm gold; anti-FAF IgG,
20 nm gold). Following negative staining,
samples were analysed by electron
microscopy. The bar represents 100 nm.
A selected area indicated by the square is
shown at higher resolution; bar represents
50 nm.
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that protein FAF at the bacterial surface and in solution
protects F. magna from the bactericidal effect of LL-37. In
addition, recombinant FAF inhibited the bactericidal activ-
ity of LL-37 (0.9 mM) against group G streptococci,
S. aureus and E. coli (data not shown), further emphasiz-
ing the inhibitory effect of FAF on this antibacterial
peptide.
Discussion
Our current understanding of the biology of the anaerobic
commensal microbiota is limited despite the fact that a
large number of anaerobic bacterial species colonize all
non-sterile body surfaces, and many questions concern-
ing fundamental prerequisites for the successful coloni-
zation of the human host by these bacteria remain
unanswered. Where in the tissue are they located? What
is the molecular basis for adherence and colonization,
and how do they cope with host defences, including anti-
bacterial peptides? These defence mechanisms should
primarily be directed against pathogens but will presum-
ably have a profound impact also on members of the
normal microbiota. To address these questions is rele-
vant from a general biological point of view, but it is also of
interest in relation to infection medicine. The host–
pathogen relationship represents a delicate balance, and
modern medicine is gradually increasing the pathogenic
potential and signiﬁcance of commensals. The wide-
spread use of antibiotics causes disturbances in the
ecology of the normal microbiota. In addition, a growing
elderly population, the introduction of foreign materials
and devices (prosthetic heart valves, joint replacements,
catheters, etc.) and a rapidly expanding number of indi-
viduals treated with immunosuppressive drugs have
created a situation where the clinical signiﬁcance of
opportunistic pathogens, including anaerobes, has
increased dramatically during the last decades.
Finegoldia magna, the subject of the present investiga-
tion, is a major constituent of the normal anaerobic micro-
biota, and previous studies have also demonstrated its
growing importance as a pathogen (for references see
Murdoch, 1998). During cultivation of F. magna we
noticed that a majority of the isolates formed large bacte-
rial aggregates and that the culture supernatants some-
times contained visible proteinaceous precipitates. These
observations initiated the present study and led to the
discovery of protein FAF. FAF was found to mediate bac-
terial aggregation through protein–protein interactions
between FAF molecules on neighbouring F. magna
bacteria. Presumably, these interactions will play a role
also in vivo by establishing contact between bacteria
and facilitating adherence and colonization. The a-helical
coiled-coil structure of FAF explains the elongated ﬁbrous
appearance of the protein. It is noteworthy that M proteins
of the human pathogen S. pyogenes (for references see
Fischetti, 1989) are also a-helical coiled-coil surface pro-
teins (Phillips et al., 1981) that promote bacterial aggre-
gation (Frick et al., 2000). FAF and M proteins show no
sequence homology, but obviously their related overall
structure and localization have similar functional
consequences. Moreover, FAF and M proteins are also
both released from the bacterial surface. In the case of M
proteins, proteolytic enzymes, secreted by S. pyogenes
or by activated neutrophils, solubilize surface-associated
M protein into the environment (Berge and Björck, 1995;
Herwald et al., 2004). Interestingly, F. magna secretes a
subtilisin-like proteinase, SufA(Karlsson et al., 2007), and
ongoing work in our laboratory has demonstrated that
this enzyme efficiently releases a 53 kDa FAF fragment
similar to the fragment released by CNBr described here
(Fig. 2). Like the M proteins that are classical virulence
determinants of S. pyogenes interacting with several host
molecules, such as ﬁbrinogen, albumin, plasminogen and
IgG (for references see Cunningham, 2000), FAF could
be important for the pathogenesis of F. magna.
Prior to this study, no data have been published
describing the precise localization of F. magna in a human
tissue. In normal healthy skin, electron microscopy and
FAF antibodies identiﬁed F. magna at the basement mem-
brane at the epidermal/dermal junction. Thanks to a gen-
erous gift from the late Dr Rupert Timpl, we could analyse
a unique collection of highly puriﬁed basement membrane
proteins and their interactions with FAF. These studies
revealed that BM-40, a non-collagenous glycoprotein
(also called SPARC or osteonectin), is the ligand for FAF.
Originally isolated from bone (Termine et al., 1981),
BM-40 has later been identiﬁed in numerous other tissues
(for a review see Brekken and Sage, 2000), and the
protein is present extracellularly both in the epidermal
and in the dermal compartments of the skin. In FAF,
the binding site for BM-40 is in the C-terminal part of
the protein. In contrast to the variable N-terminal, the
C-terminal part is conserved among FAF homologues,
suggesting an evolutionary pressure to preserve this
region and underlining the biological signiﬁcance of the
FAF–BM-40 interaction. Apart from skin, F. magna also
colonizes other epithelial surfaces. The fact that there are
F. magna isolates that do not carry the faf gene indicates
that strains in other ecological niches utilize other mecha-
nisms than FAF–BM-40 interactions for colonization.
Most of the FAF-expressing strains of this study (20 of
28) also express the albumin-binding PAB protein (de
Château and Björck, 1994). Previous work has demon-
strated that the binding of albumin to F. magna promotes
their growth (de Château et al., 1996), and it is interesting
that BM-40 was reported to increase albumin transport
across the endothelium (Goldblum et al., 1994). Hypo-
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transport and thereby bacterial multiplication. F. magna is
among the most frequently isolated bacterial species
from chronic leg ulcers (Wall et al., 2002; Stephens et al.,
2003). In vitro, growth medium from such F. magna iso-
lates inhibits the proliferation of ﬁbroblasts and kerati-
nocytes (Stephens et al., 2003). Soluble BM-40 is found
in wound ﬂuid and was reported to stimulate wound
healing, angiogenesis and cell proliferation (for refer-
ences see review Brekken and Sage, 2000). Moreover, an
increased production of BM-40 is induced in ﬁbroblasts by
transforming growth factor b1 produced in remodulating
tissue (Wrana et al., 1991). Through the interaction with
BM-40, FAF-expressing F. magna and/or soluble FAF
may impair wound healing and explain why these bacteria
so commonly colonize chronic wounds.
In epidermis and on other epithelial surfaces a soluble
barrier of antimicrobial peptides (AMPs) provide a non-
speciﬁc ﬁrst line of defence against potential pathogens
(Zasloff, 2002). In case of injury and infection, AMPs are
upregulated in the skin as a result of increased synthesis
by keratinocytes and degranulation of neutrophils (Braff
et al., 2004). The AMP LL-37/hCAP18 is induced in kera-
tinocytes during inﬂammation (Frohm et al., 1997; Dor-
schner et al., 2001), while human neutrophil a-defensins
(HNP1-HNP3) are expressed also by monocytes and
natural killer cells (for references see Selsted and
Ouellette, 2005). A key observation of this study is that
FAF-expressing F. magna is more resistant to LL-37 and
that soluble FAF also binds and inactivates LL-37. FAF
showed no affinity for the a-defensin HNP1, and it is
interesting that this AMP does not kill F. magna (Karlsson
et al., 2007). Large amounts of FAF are released by
F. magna growing in vitro (Fig. 2A, lane 2) and also pre-
sumably in vivo. In the tissue, such released material
could form protective barriers surrounding colonies of
F. magna.
Opportunistic bacterial infections represent a major
and growing medical problem. To address this problem,
a better understanding of the molecular and cellular
interplay between commensal bacteria and their host is
required. The properties of FAF demonstrate that the
protein signiﬁcantly inﬂuence this interplay and help to
explain how F. magna colonizes and survives in its human
host.
Experimental procedures
Bacteria, growth conditions, analysis of bacterial
aggregation and CNBr treatment
Finegoldia magna strains (30) were isolated at the Depart-
ment of Clinical Microbiology, Lund University Hospital,
Sweden. All strains except two that were normal skin isolates
were isolated from patients with various pathological condi-
tions, mostly infected skin wounds (12). The FAF-expressing
strains that were sequenced were isolated from the following
anatomical sites: scrotal abscess (ALB8), intra-abdominal
abscess (L3410), knee infection (1766), foot wound (1462),
foot abscess (2133), normal skin (ELTI). Other sites included
liver, sinus, urethra and cervix. The 505 strain was isolated
from urethra. The bacteria were grown under strict anaerobic
conditions in Todd-Hewitt broth (TH) (Difco) supplemented
with 0.5% Tween-80 at 37°C. Group G streptococci and
S. aureus were cultivated in TH at 37°C, and E. coli was
grown in Luria–Bertani broth at 37°C. For analysis of bacterial
aggregation F. magna strains were grown for 3 days in 10 ml
test tubes. The bacteria were gently resuspended and left to
settle at 4°C, and the degree of aggregation was followed by
measuring the optical density at 620 nm in the upper half of
the tubes. ALB8 bacteria, washed with PBS (0.12 M NaCl,
0.03 M phosphate, pH 7.4), were also analysed for aggrega-
tion in presence of anti-FAF antibodies. Three millilitres bac-
terial solution [1 ¥ 10
9 colony-forming units (cfu) ml
-1] were
mixed with anti-FAF IgG (0.54 mg), and sedimentation was
measured as above. CNBr extraction of F. magna surface
proteins was performed as previously described (Otten et al.,
1992). CNBr-treated ALB8 bacteria were washed with PBS
and tested for aggregation. A portion of the cells was sub-
jected to negative staining, see below.
Proteins, peptides, coupling of proteins to Sepharose,
antibodies, labelling of proteins and binding assay
Human and bovine serum albumin (HSA and BSA) were
purchased from Sigma, and recombinant protein PAB was
prepared as described previously (de Château and Björck,
1994). The LL-37 peptide was synthesized by Innovagen
and human neutrophil protein 1 was from Bachem. Base-
ment membrane proteins (Laminin-1/Nidogen-1, Nidogen-1,
Nidogen-2, Collagen IV, BM-40, Fibulin-1C, Fibulin-2,
Laminin a1 and Laminin a2) were kindly provided by the late
Dr Rupert Timpl. The monoclonal antibody against bovine
osteonectin/BM-40, developed by Dr John D. Termine, was
obtained from the Developmental Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained
by the Department of Biological Sciencies, University of
Iowa, Iowa City, USA. Coupling of HSA to CNBr-activated
Sepharose 4B (Pharmacia) was performed according to
the manufacturer’s instructions. Puriﬁcation of protein FAF
shedded from F. magna strain ALB8 was performed as
follows. Bacterial cells were washed with PBS, subjected to
vortexing for 60 s, followed by centrifugation at 3000 ¥ g.
The supernatant was collected and incubated with HSA-
Sepharose for 3 h at 4°C. Unbound material, devoid of the
HSA-binding protein PAB, was collected and left at 4°C. The
precipitated material was dissolved in PBS and subjected to
dialysis against the same buffer. Antibodies against recombi-
nant protein FAF were raised in rabbits, and anti-protein FAF
IgG was puriﬁed on a protein G-Sepharose column (Amer-
sham Bioscience). Anti-FAF antiserum was applied to the
column, and following extensive washing with PBS bound
IgG was eluted with 0.1 M glycine-HCl, pH 2.0. Eluted IgG
was dialysed against PBS. Recombinant protein FAF, frag-
ments of FAF, HSA and human BM-40 were radiolabelled
with
125I using IODO-BEADS
® Iodination reagent (Pierce).
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125I-labelled proteins to F. magna bacteria was
performed as described earlier (Björck and Kronvall, 1984).
Electrophoresis, Western blot analysis and analysis of
proteins applied to PVDF membranes
The SDS-PAGE was performed using the buffer system by
Laemmli. The polyacrylamide content was 10% in the sepa-
ration gels with a cross-linking of 2.7%. Samples were boiled
for 3 min in an equal volume of sample buffer containing 2%
SDS and 5% 2-mercaptoethanol. Gels were stained with
Coomassie brilliant blue or transferred to PVDF membranes
(Immobilon, Millipore) for Western blot analysis. Proteins
were also directly applied to PVDF membranes using a
Milliblot-D system (Millipore). The membranes were blocked,
incubated with
125I-labelled proteins and washed as previ-
ously described (Åkesson et al., 1990). Bound ligand was
detected using the Fuji Imaging System. Alternatively, mem-
branes were blocked with PBS containing 0.05% Tween-20
(PBST) and 5% dry milk powder (blocking buffer), incubated
with antibodies against FAF (1:1000) in blocking buffer for
30 min at 37°C, washed with PBST and incubated with
peroxidase-conjugated protein A (Sigma) 1:3000 in blocking
buffer for 30 min at 37°C. The membranes were washed with
PBST, and bound antibodies were detected using the chemi-
luminescence method.
Cloning, polymerase chain reactions, sequencing
techniques and expression of protein FAF
For cloning and sequencing of the gene encoding FAF the 5′
primer (3209) 5′-GCA(T)GAAAAA(G)GCA(T)CCA(TC)AAA
(G)AAT(CA)ACNGAAAAT(C)CT-3′ and the 3′ primer (769)
5′-GCTACCAGCTTTTGGTAA-3′ were used in PCR with
chromosomal DNA from F. magna strain ALB8. A fragment of
1.7 kb was generated, cloned and sequenced (see below).
Two primers, based on the sequence retrieved from the
1.7 kb product, were synthesized to obtain the signal
sequence and the terminal 3′-end of faf. The 5′ primer (4244)
5′-GTTATCGACAAAGGAACTATCG-3′ from the 3′-end of
the 1.7 kb sequence and the 3′primer (4292) 5′-CAGA
AGCCCATGGTTGAGCTAC-3′ from the 5′-end of the
sequence were used in PCR. As template a ligation mix of
HindIII-cleaved genomic DNA from F. magna strain ALB8
and a HindIII-cleaved 450 bp PCR fragment generated
with genomic DNA from F. magna strain KA were used. The
450 bp product was generated with the 5′ primer (KAN1)
5′-GTCACATGTTAGCAGTAACAAC-3′ and the 3′ primer
(KAC1) 5′-GAAGTTGATGAGTCACCATTCATG-3′. This KA
fragment contains a HindIII site, and the fragments obtained
after cleavage were used as adaptors to the HindIII-cleaved
fragments from ALB8. Primers KAN1 and 4292 generated a
0.6 kb PCR fragment and primers 4244 and KAC1, a frag-
ment of 0.48 kb. The PCR products were cloned into the
T/A-vector pGEM-T (Promega) according to the instructions
from the manufacturer. Positive clones were sequenced.
For expression of the mature protein FAF (a.a. 28–616) in
E. coli, faf was PCR ampliﬁed using the 5′ primer (faf1)
5′-GCAGAATTCGCAGAAAAAGCCCCAAAGATTACTGAAA-
3′, containing an EcoRI site and the 3′ reverse primer (faf2),
containing a NotI site, 5′-ATAGCGGCCGCTTATTATTTACGT
TTTTTAAGTGAAATA-3′. Fragments of FAF were expressed
using the following primers: for fragment I (a.a. 28–115) and
fragment II (28–317) the 5′ primer faf1 in combination with the
3′ reverse primers 5′-ATAGCGGCCGCTTATTAAGCTTCTT
TGATTGCTTTGTA-3′ for fragment I and 5′-ATAGCGGCCGC
TTATTATTCTTTAGATGCTGCATCGAA-3′ for fragment II
containing a NotI site. For expression of fragment III (a.a.
239–616) the 5′ primer, containing an EcoRI site, 5′-GCA
GAATTCGGTGGATGGAATGGATCTGCA-3′, was used to-
gether with the 3′ reverse primer faf2. The DNA fragments
were cloned into pGEX-6p-1 (Amersham Pharmacia). The
FAF constructs, fused to GST, were expressed and puriﬁed
on glutathione Sepharose according to the manufacturer’s
instructions. Where required the GST-tag was cleaved off
using PreScission protease (Amersham Pharmacia).
To investigate the occurrence of faf in F. magna isolates,
PCR was performed using the following primers: faf1 and
faf2, generating a 1700 bp fragment corresponding to the
mature protein FAF; the 5′ primer (fafNdown) 5′-GAAA
CAGCAAAGAAAAAAGCTTAT-3′ hybridizing with nucle-
otides 377–400 and the 3′ reverse primer (3downfaf)
5′-CTTTTTAGTATAATCTATTTGCG-3′ hybridizing with nu-
cleotides 1977–98 in the faf gene; the 5′ primer (signal)
5′-ATGAAATTAAACAAAAAATTATTGAC-3′ hybridizing with
nucleotides 121–146 and the 3′ reverse primers (faf3)
5′-CAGTAACTTTGTATGCTCTTTGG-3′ hybridizing with
nucleotides 1086–1108, or (faf4) 5′-CGATGTCTCCGT
TTTCATCAG-3′ hybridizing with nucleotides 1469–1489 in
the faf gene. Thirty isolates were analysed and fragments
were generated as follows: faf1/faf2 in 13.8%, fafNdown/
3downfaf in 27.6%, signal/faf3 in 93.3%, signal/faf4 in 75.9%
and signal/3downfaf in 93.3% of the strains. The PCR prod-
ucts from strains L3410, 1462, 2133, ELTI and 1766 were
puriﬁed with a High Pure PCR puriﬁcation kit (Roche Applied
Science) and used as templates in sequencing reactions
using an ABI PRISM
® BigDye™ dideoxy terminator kit
(BigDye terminator version 3.1 cycle sequencing Ready
Reaction, Applied Biosystem), according to the manufactur-
er’s instructions. The nucleotide sequences have been sub-
mitted to the GenBank/NCBI under accession numbers:
AY192570 strain ALB8, EF577478 strain L3410, EF577479
strain 1462, EF577480 strain 2133, EF577481 strain
ELTI, EF577482 strain 1766. Protein domains were identi-
ﬁed using the InterProScan program (http://www.ebi.ac.uk/
Tools/InterProScan).
Amino acid sequence analysis, CD spectroscopy and
computational sequence analysis
Samples subjected to N-terminal amino acid sequencing
were separated by SDS-PAGE, transferred to a PVDF mem-
brane, stained with Coomassie brilliant blue, and the protein
bands were cut out from the membrane. Sequence analyses
were performed at Eurosequence (the Netherlands). CD
spectra of recombinant protein FAF were recorded on a
Jasco J-720 spectropolarimeter equipped with a thermo-
stated cell holder. The spectra were recorded in the far UV
region (260–185 nm) in cells with path lengths of 0.02 cm.
The buffer used in the experiments was 10 mM phosphate
buffer, pH 7.5, and spectra were recorded for protein concen-
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-1 respectively. Coiled-coil
predictions were calculated by the program Macstripe, using
a 28-residue window, as previously described (Nilson et al.,
1995). The BLAST Network server at the National Center for
Biotechnology Information was used for similarity searches
(Altschul et al., 1990).
Surface plasmon resonance spectroscopy
The different basement membrane components were diluted
with 10 mM sodium acetate, pH 4.0 and immobilized via
amine coupling in different ﬂow cells of a CM5 sensorchip
(BIAcore, Uppsala, Sweden). Immobilization levels were
around 1500 resonance units. For affinity measurements,
binding and dissociation were monitored in a BIAcore 2000
instrument. Proteins FAF and PAB were injected at concen-
trations ranging from 31 nM to 250 nM, over the coated sur-
faces at 50 ml min
-1 and 25°C (in running buffer: 10 mM
Hepes, pH 7.5, 150 mM NaCl, 0.005% surfactant P20 and
3.4 mM EDTA). A ﬂow cell subjected to the coupling reaction
without protein was used as a control for bulk resonance
changes. The basement membrane surfaces were regener-
ated by injection of a 200 ml pulse of running buffer containing
2 M NaCl followed by an extensive wash. After X and Y
normalization, the blank curves from the control ﬂow cell of
each concentration were subtracted, and association (ka) and
dissociation (kDa) rate constants were determined using a
Langmuir ﬁt in the BIA Evaluation 3.0 program. The equilib-
rium dissociation constants (KD) were calculated from these
values.
Bactericidal assay
Finegoldia magna strains ALB8 and 505 were grown to mid-
log phase (A620 ª 0.4–0.6) in TH broth (supplemented with
0.5% Tween-80), washed and diluted in 10 mM Tris-HCl,
pH 7.5, containing 5 mM glucose. 50 ml of bacteria
(2 ¥ 10
6 cfu ml
-1) was anaerobically incubated with LL-37 at
various concentrations for 1 h at 37°C. To quantify the bac-
tericidal activity serial dilutions of the incubation mixtures
were plated on TH agar, incubated anaerobically for up to
3 days, and the number of cfu was determined. In subse-
quent experiments, 505 bacteria were incubated for 1 h with
LL-37 at a concentration of 2.2 mM together with different
amounts of protein FAF. S. aureus, group G streptococci and
E. coli, respectively, were incubated with LL-37 at a concen-
tration of 0.9 mM together with different amounts of protein
FAF, and the bactericidal activity was quantiﬁed.
Adherence to human skin
Punch biopsies (4 mm diameter) of human skin were
obtained in connection with skin transplant surgery. Informed
consent was obtained from the patients. The Ethics Commit-
tee at Lund University approved the use of this material
(permit numbers LU 509–01 and LU 708–01). The biopsies
were incubated with F. magna bacteria (2 ¥ 10
8 bacterial
cells) in PBS for 1 h at room temperature and washed with
PBS to remove non-adherent bacteria. Minimal essential
medium (MEM; Life technologies) was added, and the
samples were incubated anaerobically at 37°C for 48 h. Fol-
lowing a washing step with PBST samples were ﬁxed in 2.5%
glutaraldehyde in 0.15 M sodium cacodylate, pH 7.4 and pre-
pared for SEM (see below). For colocalization experiments
antibodies were gold-labelled as described (Baschong and
Wrigley, 1990): anti-protein FAF (10 nm gold) and anti-BM-40
(5 nm gold). Biopsies were incubated and washed as above,
incubated with gold-labelled antibodies, washed and pre-
pared for ultrathin sectioning and transmission electron
microscopy. In some experiments, biopsies were subjected to
low temperature embedding in Lowicryl, ultrathin sectioning
and transmission electron microscopy without prior incuba-
tion with F. magna bacteria.
Electron microscopy
For SEM 20 ml of bacterial cultures, containing 2 ¥ 10
9 bac-
terial cells ml
-1 in PBS, was added on top of a poly L-lysine-
coated glass coverslip for 30 min. Subsequently specimens
were ﬁxed in 2.5% glutaraldehyde in 0.15 M sodium cacody-
late, pH 7.4 for 2 h at room temperature, washed and stored
in 0.15 M cacodylate buffer, pH 7.4. Fixed specimens were
dehydrated for 10 min at each step of an ascending ethanol
series and inserted into a Balzers critical point dryer using
100% ethanol as the intermediate solvent. The pressure
chamber was then extensively ﬂushed three times with
carbon dioxide to remove all traces of residual ethanol. The
samples were critical point dried, mounted on aluminium
holders, palladium/gold sputtered and examined in a Jeol
ST300 SEM.
For transmission electron microscopy bacterial cells were
collected by centrifugation at 3000 ¥ g, ﬁxed for 1 h at room
temperature and then overnight at 4°C in 2.5% glutaralde-
hyde in cacodylate buffer. Samples were washed with
cacodylate buffer, post-ﬁxed for 1 h at room temperature in
1% osmium tetroxide in cacodylate buffer, dehydrated in a
graded series of ethanol and then embedded in Epon 812
using acetone as intermediate solvent. Specimens were sec-
tioned with a diamond knife into 50 nm-thick ultrathin sections
on an LKB ultramicrotome. The ultrathin sections were
stained with uranyl acetate and lead citrate. Specimens were
observed in a Jeol JEM 1230 electron microscope operated
at 80 kV accelerating voltage, and images were recorded
with a Gatan Multiscan 791 CCD camera.
The following samples were prepared for negative staining:
extract of ALB8 bacteria heated at 80°C for 10 min, recom-
binant protein FAF (0.1 mg ml
-1), complexes of protein FAF
and BM-40 preformed by incubation of equimolar concentra-
tions (2 nM) for 20 min at room temperature, untreated and
CNBr-treatedALB8 bacteria (100 ¥ 10
6 cfu) washed with TBS
(50 mM Tris-HCl, pH 7.5, 0.15 M NaCl), ALB8 and 505 bac-
teria (100 ¥ 10
6 cfu) incubated with gold-labelled LL-37 (5 ng;
5 nm gold) and anti-FAF antibodies (20 nm gold) for 30 min at
room temperature. Samples were adsorbed onto a 400-mesh
carbon-coated copper grid, which was rendered hydrophilic
by glow discharge at low pressure in air. The grid was imme-
diately blotted, brieﬂy washed with two drops of water and
stained with 0.75% uranyl formate for 15 s. Specimens were
studied in a Jeol 1200 EX transmission electron microscope
operated at 60-kV accelerating voltage and ¥75 000
magniﬁcation.
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